-
UPDATE: Benchmark Downgrades Meredith Corporation To Hold, Lowers PT To $37
Thursday, April 28, 2011 - 9:19am | 190Read More...Benchmark is lowering its rating on Meredith (NYSE: MDP) from Buy to Hold as soft National Media trends may persist in the near-term, hindering share appreciation. Meredith reported F3Q11 net revenue of $341 million, down 4% y/y, falling short of consensus of $352 million. Results were driven by an...
-
Benchmark Gives Update On Moody's After Reporting Strong Earnings
Thursday, April 28, 2011 - 9:14am | 156Read More...Moody's (NYSE: MCO) reported strong 1Q11 results and raised 2011 guidance. 1Q11 total revenue of $577 million, up 21% y/y, beat consensus of $521 million and Benchmark's estimate of $531 million, as all revenue segments increased y/y. EPS of $0.67 beat consensus of $0.54 and Benchmark's estimate of...
-
Benchmark Gives Update On iRobot Corporation Following Earnings; Raises PT To $40
Thursday, April 28, 2011 - 9:09am | 181Read More...iRobot (NASDAQ: IRBT) reported Q1FY11 sales of $106 million and EPS of $0.27 vs. a consensus estimate of $104 million and $0.23. Revenue grew by 12% y/y, with EPS up 15% on a 700 bps gross margin improvement. Management reaffirmed its FY11 outlook, including sales of $450-465 million and EPS...
-
Benchmark Raises Its PT On InfoSpace To $11 After Reporting A Strong Quarter
Thursday, April 28, 2011 - 9:03am | 179Read More...InfoSpace (NASDAQ: INSP) reported a beat and raise quarter. Its search distribution segment grew 14% sequentially and drove the strong performance. Benchmark raises its 2011E EBITDA from $18 million to $24 million. Its price target rises from $10 to $11 per share and it maintains a Buy rating on...
-
Benchmark Initiates Coverage On Exact Sciences Corporation At Buy, $9 PT
Thursday, April 28, 2011 - 8:56am | 195Read More...Benchmark is initiating coverage of Exact Sciences Corporation (NASDAQ: EXAS) with a Buy rating and $9 price target. Exact is developing the Cologuard stool-based DNA test with the intention of being the first non-invasive screening diagnostic that can prevent colorectal cancer by detecting...
-
Benchmark Initiates Coverage On Exact Sciences Corporation At Buy, $9 PT
Thursday, April 28, 2011 - 8:56am | 195Read More...Benchmark is initiating coverage of Exact Sciences Corporation (NASDAQ: EXAS) with a Buy rating and $9 price target. Exact is developing the Cologuard stool-based DNA test with the intention of being the first non-invasive screening diagnostic that can prevent colorectal cancer by detecting...
-
Benchmark Comments On Equinix Following Earnings Report
Thursday, April 28, 2011 - 8:52am | 193Read More...Equinix (NASDAQ: EQIX) reported strong 1Q11 results with revenue up 22% organically. EBITDA at $167 million, was $15 million ahead of the street. Benchmark increases its 2011 estimates, driving the price target to $115 from $105 and maintains a Buy rating. Equinix's 1Q11 beat was due to better-...
-
Benchmark Comments On Belo Corp Following Solid Earnings
Thursday, April 28, 2011 - 8:30am | 181Read More...Belo Corp. (NYSE: BLC) reported 1Q11 total revenue of $151 million, down 2% y/y, matching consensus but slightly below Benchmark's $154 million estimate. Adjusted EBITDA fell by 14% y/y to $41 million, in line with Benchmark's estimate, driven by a lower than anticipated increase in costs. Adjusted...
-
UPDATE: Benchmark Downgrades Open Text to Sell (OTEX)
Thursday, April 28, 2011 - 8:07am | 146Read More...Benchmark is out with its report today on Open Text (NASDAQ: OTEX), downgrading OTEX from Hold to Sell. In a note to clients, Benchmark writes, "We are lowering our rating on OTEX to Sell from Hold and establishing a $56 price target. Our downgrade is based on our belief that the stock is likely...
-
Benchmark Maintains Buy on Crown Castle International (CCI)
Thursday, April 28, 2011 - 8:00am | 98Read More...Benchmark is out with its report today on Crown Castle International (NYSE: CCI), maintaining Buy. In a note to clients, Benchmark writes, "Crown Castle reported sustained growth in 1Q11 and left its 2011 guidance unchanged. CCI has begun to buyback its stock. Tower trends remain solid with...
-
UPDATE: Benchmark Raises PT on eBay to $36 (EBAY)
Thursday, April 28, 2011 - 7:57am | 111Read More...Benchmark is out with its report today on eBay (NASDAQ: EBAY), raising its PT from $30 to $36. In a note to clients, Benchmark writes, "eBay posted solid 1Q11 earnings with total revenue of $2.5 billion, in-line with our estimate and above street consensus, reflecting 16% y/y growth. The 2Q11 and...
-
Benchmark Maintains Hold Rating, $18 PT On VCLK Amid Greystripe Acquisition
Monday, April 25, 2011 - 12:22pm | 134Read More...ValueClick, Inc. (NASDAQ: VCLK) announced the acquisition of mobile advertising network Greystripe, “an impressive 1Q11 beat, and a 3% stock repurchase,” Benchmark reports. “This morning's moderate stock reaction appears appropriate as our analysis indicates that the proforma EBITDA multiple drops...
-
Dahlman Rose Comments On Core Laboratories Following Recent Earnings Report
Wednesday, April 20, 2011 - 8:04am | 197Read More...Core Laboratories (NYSE: CLB) reported earnings of $0.77 per share, matching our $0.77 EPS estimate and above the consensus of $0.75. In the press release the company guided earnings for 2011 to a $3.55-$3.60 per share range, compared to Dahlman Rose's $3.76 per share estimate and a consensus of $3...
-
UPDATE: Benchmark Upgrades Lamar Advertising Company
Wednesday, April 20, 2011 - 7:49am | 217Read More...Benchmark raise its rating on Lamar Advertising (NASDAQ: LAMR) from Hold to Buy given the year to date 20% correction in Lamar's stock and the likelihood that Lamar can deliver reliable growth as the advertising recovery is sustained. Lamar may still reach its 1Q11 guidance of $256 million in...
-
Benchmark Comments On Journal Communications Following Earnings Miss
Wednesday, April 20, 2011 - 7:44am | 198Read More...Journal Communications (NYSE: JRN) reported 1Q11 results which fell just shy of expectations. Total revenue of $84 million was $1 million below consensus due to ongoing weakness in Community Newspapers and Shoppers, while Broadcast results were mostly in line. EBITDA fell 25% to $12 million on an...

